STOCK TITAN

Schwartz Investment Trust - Ave Maria Undiscovered Fund Stock Price, News & Analysis

AVEUX Nasdaq

Welcome to our dedicated page for Schwartz Investment Trust - Ave Maria Undiscovered Fund news (Ticker: AVEUX), a resource for investors and traders seeking the latest updates and insights on Schwartz Investment Trust - Ave Maria Undiscovered Fund stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Schwartz Investment Trust - Ave Maria Undiscovered Fund's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Schwartz Investment Trust - Ave Maria Undiscovered Fund's position in the market.

Rhea-AI Summary

Ave Maria Mutual Funds (AVEUX) marks its 25th anniversary and launches the new Ave Maria Undiscovered Fund (AVEUX) on April 30, 2026. The fund targets long-term capital appreciation, emphasizing companies with market capitalizations typically $10 billion or less and is managed by Ryan Kuyawa, Sean Gaffney, and James Peregoy.

The firm continues to apply its Catholic screening to exclude investments linked to abortion, pornography, embryonic stem cell research, or anti-family practices.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
none